| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |